Press release
Ankylosing Spondylitis Pipeline Drugs and Companies Insight Report (2023): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Ankylosing Spondylitis Overview
Ankylosing Spondylitis, is a form of arthritis that primarily affects the spine. It causes severe inflammation of the spinal joints (Vertebrae) that can lead to chronic pain and discomfort. The hallmark feature of Ankylosing spondylitis is the involvement of sacroiliac (SI) joints during the progression of disease
The Ankylosing Spondylitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Ankylosing Spondylitis Pipeline Report: https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Ankylosing Spondylitis treatment therapies with a considerable amount of success over the years. Ankylosing Spondylitis Key players such as - Qyuns Therapeutics, Kinevant Sciences, MoonLake Immunotherapeutics, Izana Bioscience, Suzhou Zelgen Biopharmaceuticals, Sun Pharma Global, Jiangsu HengRui Mediicne, UCB, Amgen, and others, are developing therapies for the Ankylosing Spondylitis treatment
• Ankylosing Spondylitis Emerging therapies such as - QX 002N, KIN-1901, Sonelokimab, Namilumab, Jaktinib, Tildrakizumab, SHR0302, Bimekizumab, Apremilast, and others are expected to have a significant impact on the Ankylosing Spondylitis market in the coming years.
• Jiangsu HengRui initiated phase II/III, multicenter, randomized, double-blind, placebo-controlled adaptive seamless clinical study to evaluate the efficacy and safety of SHR0302 in active ankylosing spondylitis subjects
• UCB Biopharma initiated a phase III multicenter, randomized, double-blind, placebo controlled study to evaluate the safety and efficacy of Bimekizumab in subjects with active ankylosing spondylitis. With the enrollment of 332 participants, the trial is in active, not recruiting stage and was completed by September 2022
Ankylosing Spondylitis Pipeline Therapeutics Assessment
• Ankylosing Spondylitis Assessment by Product Type
• Ankylosing Spondylitis By Stage and Product Type
• Ankylosing Spondylitis Assessment by Route of Administration
• Ankylosing Spondylitis By Stage and Route of Administration
• Ankylosing Spondylitis Assessment by Molecule Type
• Ankylosing Spondylitis by Stage and Molecule Type
DelveInsight's Ankylosing Spondylitis Report covers around 40+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Ankylosing Spondylitis Drugs Under Different Phases of Clinical Development Include:
• QX 002N: Qyuns Therapeutics
• KIN-1901: Kinevant Sciences
• Sonelokimab: MoonLake Immunotherapeutics
• Namilumab: Izana Bioscience
• Jaktinib: Suzhou Zelgen Biopharmaceuticals
• Tildrakizumab: Sun Pharma Global
• SHR0302: Jiangsu HengRui Mediicne
• Bimekizumab: UCB
• Apremilast: Amgen
Get a Free Sample PDF Report to know more about Ankylosing Spondylitis Pipeline Assessment- https://www.delveinsight.com/sample-request/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Ankylosing Spondylitis Pipeline Analysis:
The Ankylosing Spondylitis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Ankylosing Spondylitis treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Ankylosing Spondylitis Treatment.
• Ankylosing Spondylitis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Ankylosing Spondylitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Ankylosing Spondylitis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Ankylosing Spondylitis product details are provided in the report. Download the Ankylosing Spondylitis pipeline report to learn more about the emerging Ankylosing Spondylitis therapies at:
https://www.delveinsight.com/sample-request/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Ankylosing Spondylitis Pipeline Market Drivers
• Rising prevalence of Ankylosing spondylitis
• Increase in Drug Development for Ankylosing spondylitis
• Decrease quality of life
Ankylosing Spondylitis Pipeline Market Barriers
• Lack of early diagnosis of the disease
• Minimum participation of patients in physical activity
• High treatment cost and lack of caregiver
Scope of Ankylosing Spondylitis Pipeline Drug Insight
• Coverage: Global
• Key Ankylosing Spondylitis Companies: Qyuns Therapeutics, Kinevant Sciences, MoonLake Immunotherapeutics, Izana Bioscience, Suzhou Zelgen Biopharmaceuticals, Sun Pharma Global, Jiangsu HengRui Mediicne, UCB, Amgen, and others
• Key Ankylosing Spondylitis Therapies: QX 002N, KIN-1901, Sonelokimab, Namilumab, Jaktinib, Tildrakizumab, SHR0302, Bimekizumab, Apremilast, and others
• Ankylosing Spondylitis Therapeutic Assessment: Ankylosing Spondylitis current marketed and Ankylosing Spondylitis emerging therapies
• Ankylosing Spondylitis Market Dynamics: Ankylosing Spondylitis market drivers and Ankylosing Spondylitis market barriers
Request for Sample PDF Report for Ankylosing Spondylitis Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Ankylosing Spondylitis Report Introduction
2 Ankylosing Spondylitis Executive Summary
3 Ankylosing Spondylitis Overview
4 Ankylosing Spondylitis- Analytical Perspective In-depth Commercial Assessment
5 Ankylosing Spondylitis Pipeline Therapeutics
6 Ankylosing Spondylitis Late Stage Products (Phase II/III)
7 Ankylosing Spondylitis Mid Stage Products (Phase II)
8 Ankylosing Spondylitis Early Stage Products (Phase I)
9 Ankylosing Spondylitis Preclinical Stage Products
10 Ankylosing Spondylitis Therapeutics Assessment
11 Ankylosing Spondylitis Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Ankylosing Spondylitis Key Companies
14 Ankylosing Spondylitis Key Products
15 Ankylosing Spondylitis Unmet Needs
16 Ankylosing Spondylitis Market Drivers and Barriers
17 Ankylosing Spondylitis Future Perspectives and Conclusion
18 Ankylosing Spondylitis Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Ankylosing Spondylitis drugs and therapies- https://www.delveinsight.com/sample-request/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Ankylosing Spondylitis Market https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Ankylosing Spondylitis-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Ankylosing Spondylitis Epidemiology https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Ankylosing Spondylitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports By DelveInsight -
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ankylosing Spondylitis Pipeline Drugs and Companies Insight Report (2023): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2912483 • Views: 247
More Releases from DelveInsight Business Research
Graves' Ophthalmopathy Market to witness growth by 2032, estimates DelveInsight …
DelveInsight's "Graves' Ophthalmopathy Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Graves' Ophthalmopathy market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
To know more about the Graves' Ophthalmopathy market report offerings, click here: https://www.delveinsight.com/report-store/graves-ophthalmopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Graves' Ophthalmopathy Market Key…
Anterior Uveitis Market to Witness Growth by 2032, Estimates DelveInsight | Nova …
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Anterior Uveitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Anterior Uveitis market size…
Postoperative Pain Pipeline Drugs Analysis Report, 2023: Clinical Trials, Therap …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Postoperative Pain pipeline constitutes 7+ key companies continuously working towards developing 8+ Postoperative Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Postoperative Pain Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.
The Postoperative Pain…
Myelofibrosis Pipeline Drugs Analysis Report, 2023: Clinical Trials, Therapies, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myelofibrosis pipeline constitutes 7+ key companies continuously working towards developing 8+ Myelofibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Myelofibrosis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myelofibrosis Market.
The Myelofibrosis Pipeline report embraces in-depth commercial…
More Releases for Ankylosing
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate the…
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen…
Ankylosing Spondylitis Treatment Market Research and Forecast 2020-2026
The global ankylosing spondylitis treatment market is projected to exhibit considerable growth during the forecast period (2020-2026). Ankylosing spondylitis is an inflammatory disease that leads to the fusion of some small bones of the spine (vertebrae) making the spine less flexible. The rising geriatric population is expected to be a major cause responsible for ankylosing spondylitis. The rising focus of the players operating in the ankylosing spondylitis market towards investment…
Ankylosing Spondylitis Market Shares, Strategies and Forecast Worldwide, 2017 - …
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it…
Ankylosing Spondylitis Treatment Market Pegged for Robust Expansion During 2015 …
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons.
These symptomatic changes may be mild or severe, and may lead to a stooped-over posture.…
Ankylosing Spondylitis Market : New Study Offers Insights for 2025
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it…
